RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: There are inconsistencies in the results reported in a small number of previous studies into growth hormone (GH) treatment in Korean children with idiopathic short stature (ISS) and idiopathic growth hormone deficiency (IGHD). Thus, the authors retrospectively compared the effects of GH in ISS and IGHD. Methods: From the medical records of 26 ISS and 30 IGHD children, auxological and biochemical changes including chronologic age (CA), bone age (BA), height standard deviation score (HT-SDS), predicted adult height (PAH), midparental height (MPH), insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-3 (IGFBP-3) were compared. Results: Before treatment, IGHD group had younger BA, lower BA/CA ratio, and lower IGF-1 level than those in the ISS group. During GH treatment, the levels of IGF-1 and IGFBP-3 were not different. Although annual BA increment was higher in IGHD group, and annual PAH-SDS increment was higher in ISS group, annual HT-SDS increments were not different. Both HT-SDS and PAH-SDS in the ISS group increased significantly until the end of the second year, and then those were not significantly different from MPH-SDS. In the IGHD group, the HT-SDS showed a significant increase till the end of the second year, and the PAH-SDS was not significantly changed at each year, but both HT-SDS and PAH-SDS were not significantly different from MPH-SDS at the end of the third year. Conclusion: During GH treatment, both HT-SDS and PAH-SDS approached the genetic target range of MPH-SDS after 2 years in ISS children and 3 years in IGHD children.

참고문헌 (Reference)

1 최임정, "특발성과 기질성 성장호르몬 결핍증 환아에서 성장호르몬 치료 후 최종 성인신장과 신장 증가에 영향을 미치는 인자" 대한소아과학회 46 (46): 803-810, 2003

2 강정철, "성장호르몬 결핍증과 특발성 저신장증 환아에서 성장호르몬의 치료 효과" 대한소아과학회 47 (47): 310-318, 2004

3 Cohen P, "Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children" 95 : 2089-2098, 2010

4 Ranke MB, "Towards a consensus on the definition of idiopathic short stature" 45 (45): 64-66, 1996

5 Savage MO, "The variability of responses to growth hormone therapy in children with short stature" 16 (16): S178-S184, 2012

6 Park P, "The role of insulin-like growth factor I monitoring in growth hormone-treated children" 62 (62): 59-65, 2004

7 Bayley N, "Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards" 40 : 423-441, 1952

8 Kim DH, "Response of growth hormone treatment to final height in children with growth hormone deficiency and familial short stature" 4 : 159-169, 1999

9 Hyun SE, "Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents" 45 : 16-21, 2012

10 McCaughey ES, "Randomised trial of growth hormone in short normal girls" 351 : 940-944, 1998